Long noncoding RNA LINC00482 silencing sensitizes non-small cell lung cancer cells to cisplatin by downregulating CLASRP via E2F1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long noncoding RNA LINC00482 silencing sensitizes non-small cell lung cancer cells to cisplatin by downregulating CLASRP via E2F1

Published:2023-11-15 Issue:4 Volume:23 Page:
ISSN:1438-793X
Container-title:Functional & Integrative Genomics
language:en
Short-container-title:Funct Integr Genomics

Author:

Lin Yanming,Li Jinmei,Li Shujun,Chen Yuting,Luo Yiping,Wang Yongcun,Yang Zhixiong

Funder

the Affiliated Hospital of Guangdong Medical University Clinical Research Project in Hospital Fund

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10142-023-01260-4.pdf

Reference40 articles.

1. Ayuk SM, Abrahamse H, Houreld NN (2016) The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. J Photochem Photobiol B 161:368–374. https://doi.org/10.1016/j.jphotobiol.2016.05.027

2. Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378. https://doi.org/10.1016/j.ejphar.2014.07.025

3. Dohopolski M, Gottumukkala S, Gomez D, Iyengar P (2021) Radiation therapy in non-small-cell lung cancer. Cold Spring Harb Perspect Med 11. https://doi.org/10.1101/cshperspect.a037713

4. Fan XX, Wu Q (2022) Decoding lung cancer at single-cell level. Front Immunol 13:883758. https://doi.org/10.3389/fimmu.2022.883758

5. Fouad S, Hauton D, D’Angiolella V (2020) E2F1: cause and consequence of dna replication stress. Front Mol Biosci 7:599332. https://doi.org/10.3389/fmolb.2020.599332

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP